International Stem Cell Corp (ISCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -209 | -131 | -331 | -899 | -2,724 |
| Depreciation Amortization | 206 | 194 | 218 | 262 | 253 |
| Accounts receivable | -484 | 173 | N/A | -441 | 1,112 |
| Accounts payable and accrued liabilities | -178 | 42 | -186 | 148 | -294 |
| Other Working Capital | -809 | -3 | -324 | -823 | 623 |
| Other Operating Activity | 1,487 | 654 | 955 | 456 | 689 |
| Operating Cash Flow | $13 | $929 | $332 | $-1,297 | $-341 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -166 | -80 | -1 | -23 | -28 |
| Purchase Sale Intangibles | -5 | -3 | -10 | -22 | -80 |
| Other Investing Activity | -5 | -3 | -10 | -22 | -80 |
| Investing Cash Flow | $-171 | $-83 | $-11 | $-45 | $-108 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 250 | 824 | 654 |
| Debt Repayment | -200 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $-200 | $N/A | $250 | $824 | $654 |
| Beginning Cash Position | 1,588 | 742 | 171 | 689 | 484 |
| End Cash Position | 1,230 | 1,588 | 742 | 171 | 689 |
| Net Cash Flow | $-358 | $846 | $571 | $-518 | $205 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13 | 929 | 332 | -1,297 | -341 |
| Capital Expenditure | -166 | -80 | -1 | -23 | -28 |
| Free Cash Flow | -153 | 849 | 331 | -1,320 | -369 |